Get the full picture
Sign in to uncover key details.
Mirum Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
989 E Hillsdale Blvd Ste 300, Foster Cit...Phone Number
(650) 667-4085Website
www.mirumpharma.comRevenue
$618.1 MillionStock Symbol
MIRMIndustry
About Mirum Pharmaceuticals
Mirum Pharmaceuticals is dedicated to creating life-changing therapies for patients with liver diseases. Mirum Pharmaceuticals, Inc is a US based rare disease biotechnology company focused on developing and commercializing therapies for serious liver and metabolic disorders, especially cholestatic liver diseases and other rare pediatric and adult conditions. Its key products include therapies for Alagille syndrome and other bile-acid related disorders.Explore more
Mirum Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Mirum Pharmaceuticals
Compare insights from companies similar to Mirum Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mirum Pharmaceuticals Tech Stack
A closer look at the technologies used by Mirum Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mirum Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Mirum Pharmaceuticals is dedicated to creating life-changing therapies for patients with liver diseases. Mirum Pharmaceuticals, Inc is a US based rare disease biotechnology company focused on developing and commercializing therapies for serious liver and metabolic disorders, especially cholestatic liver diseases and other rare pediatric and adult c... Read More
